BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Pharm Country

  Legend Biotech’s CEO Ying Huang on Cilta-cel’s High PFS in Myeloma Patients

  Legend Biotech and its partner Janssen are presenting six abstracts at the ASCO meeting in June detailing ciltacabtagene autoleucel (cilta-cel) CAR-T studies in multiple myeloma.

  May 27, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Drug Development

  Eli Lilly Collab Scores IND Approval for Dicerna’s RNAi Cardiometabolic Drug

  This is the second IND to come out of the two companies’ collaboration. They will initiate a Phase I trial of the drug in cardiometabolic diseases.

  May 27, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  DOJ Looks Into Employee Allegation of Rewriting Findings at Lilly Facility

  Lilly said it is cooperating fully with the DOJ and is in the process of conducting its own investigation into the allegations made against the company.

  May 27, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  Controlling Work Interruptions at Home

  Controlling interruptions when working from home can be challenging, but a little planning and some established rules can help.

  May 27, 2021

   · 

  4 min read

   · 

  Karen Walpole
• 

  Business

  BlueRock and Senti Collaborate to Build Smarter, Disease-Fighting Cell Therapies

  Determined to take its next-generation engineered cell therapies to the next level, BlueRock teams up with Senti Biosciences with futuristic medicines in mind.

  May 27, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Sanofi and GSK Launch Late-Stage Trial for COVID-19 Vaccine Candidate

  A two-stage Phase III clinical trial by Sanofi and GSK, is studying a COVID-19 vaccine candidate targeting the original SARS-CoV-2 strain as well as the South African B.1.351 variant.

  May 27, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  BioSpace Movers & Shakers, May 28

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  May 27, 2021

   · 

  6 min read

   · 

  Alex Keown
• 

  Policy

  Loncastuximab Tesirine-lpyl Therapy: Diffuse Large B-Cell Lymphoma

  Loncastuximab tesirine-lpyl just got accelerated approval from the U.S. Food and Drug Administration (FDA). This is a systemic therapy for people with diffuse large B-cell lymphoma (DLBCL).

  May 27, 2021

   · 

  5 min read

   · 

  Lorenzo Soliman
• 

  Drug Development

  Relief for Women: FDA Approves Heavy Menstrual Bleeding Drug

  The U.S. FDA has granted approval to MYFEMBREE, Myovant Sciences, and Pfizer’s once-daily treatment for heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

  May 27, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  BioMidwest

  Research Roundup: Even Mild COVID-19 Induces Lasting Antibody Protection and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  May 27, 2021

   · 

  5 min read

   · 

  Mark Terry